InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,628.51
(
0.23%
)
US TECH 100
19,824.00
(
0.16%
)
Dow Jones
40,184.25
(
0.46%
)
Brent Oil
84.37
(
-0.27%
)
Bitcoin
63,471.18
(
4.43%
)
Post# of 252599
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120045
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 214319

Friday, 10/20/2017 10:34:37 AM

Friday, October 20, 2017 10:34:37 AM

Post# of 252599
ENTA—Mavyret scripts for week ending 10/13/17 (according to IMS)….

TRx: 618, +17.5% vs prior week
NRx: 358, +2.0% vs prior week

We are now eleven weeks into the US launch.

(As previously noted, Mavyret’s absolute script numbers reported by IMS are low because IMS misses much of the public sector of the HCV market that ABBV is targeting.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up